0000950123-25-007031.txt : 20250805 0000950123-25-007031.hdr.sgml : 20250805 20250805170839 ACCESSION NUMBER: 0000950123-25-007031 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250805 DATE AS OF CHANGE: 20250805 EFFECTIVENESS DATE: 20250805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SAB Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001833214 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 853899721 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-553778 FILM NUMBER: 251186111 BUSINESS ADDRESS: STREET 1: 777 W 41ST ST STREET 2: SUITE 401 CITY: MIAMI BEACH STATE: FL ZIP: 33140 BUSINESS PHONE: 305-845-2813 MAIL ADDRESS: STREET 1: 777 W 41ST ST STREET 2: SUITE 401 CITY: MIAMI BEACH STATE: FL ZIP: 33140 FORMER COMPANY: FORMER CONFORMED NAME: Big Cypress Acquisition Corp. DATE OF NAME CHANGE: 20201120 D 1 primary_doc.xml X0708 D LIVE 0001833214 SAB Biotherapeutics, Inc. 777 W 41st St Suite 401 Miami Beach FL FLORIDA 33140 305 845-2813 DELAWARE None Big Cypress Acquisition Corp. Corporation true 2020 Samuel Reich 777 W 41st St Suite 401 Miami Beach FL FLORIDA 33140 Executive Officer Director Eddie Sullivan 777 W 41st St Suite 401 Miami Beach FL FLORIDA 33140 Executive Officer Director Katie Ellias 777 W 41st St Suite 401 Miami Beach FL FLORIDA 33140 Director Scott Giberson 777 W 41st St Suite 401 Miami Beach FL FLORIDA 33140 Director Christine Hamilton 777 W 41st St Suite 401 Miami Beach FL FLORIDA 33140 Director David Link 777 W 41st St Suite 401 Miami Beach FL FLORIDA 33140 Director Erick Lucera 777 W 41st St Suite 401 Miami Beach FL FLORIDA 33140 Director Andrew Moin 777 W 41st St Suite 401 Miami Beach FL FLORIDA 33140 Director William Polvino 777 W 41st St Suite 401 Miami Beach FL FLORIDA 33140 Director Jay Skyler 777 W 41st St Suite 401 Miami Beach FL FLORIDA 33140 Director Jeffrey Spragens 777 W 41st St Suite 401 Miami Beach FL FLORIDA 33140 Director Biotechnology Decline to Disclose 06b false 2025-07-21 false true true false 0 Leerink Partners LLC 39011 None None 53 STATE STREET 40TH FLOOR BOSTON MA MASSACHUSETTS 02109 CA CALIFORNIA IL ILLINOIS MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK UBS SECURITIES LLC 7654 None None 1285 AVENUE OF THE AMERICAS NEW YORK NY NEW YORK 10019 CA CALIFORNIA IL ILLINOIS MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK Oppenheimer & Co. Inc. 249 None None 85 BROAD STREET 22ND,24TH FLOOR NEW YORK NY NEW YORK 10004 CA CALIFORNIA IL ILLINOIS MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK Chardan Capital Markets, LLC 120128 None None 1 PENNSYLVANIA PLAZA SUITE 4800 NEW YORK NY NEW YORK 10019 CA CALIFORNIA IL ILLINOIS MA MASSACHUSETTS NY NEW YORK 175000000 175000000 0 false 17 10500000 0 0 false SAB Biotherapeutics, Inc. /s/ Samuel J. Reich Samuel J. Reich Chief Executive Officer 2025-08-05